Johnson & Johnson is in talks with the government of Japan and the Bill and Melinda Gates Foundation about locking up allocations of its potential Covid-19 vaccine as it prepares to kick off human trials, the company’s Chief Financial Officer Joseph Wolk told Reuters in an interview.More than a hundred vaccines are under development to try and stop the Covid-19 pandemic, and drugmakers including J&J are working to ramp up supply for their vaccines in the face of unprecedented demand.J&J has already agreed to prioritize an allocation to the United States as part of its funding agreement with the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA), Wolk said.The Bill and Melinda Gates Foundation would focus on allocating any vaccine it acquired to developing countries, Wolk added. Reuters previously reported that J&J is also in talks with the European Union.“Nothing has been finalized yet. We continue to have those discussions,” Wolk told Reuters. “People from the countries and the organizations we mentioned want to lock in a certain minimum level of capacity that they would get.”Wolk said that the “general construct” of the discussions is likely to take a form similar to AstraZeneca Plc’s deal… Read full this story
- Policy reform is key to unlock Vietnam's M&A future
- Does Your Dog Bite? How to Protect Your Dog and Yourself from Liability
- Wall Street to Main Street: News, Views and Commentary: June 7, 2006
J&J in talks with Japan, Gates Foundation to lock in deals on Covid-19 vaccine have 246 words, post on www.hindustantimes.com at July 16, 2020. This is cached page on Vietnam Art News. If you want remove this page, please contact us.